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Abstract
Background: The clinical significance of glycemic index (GI) and glycemic load (GL) is inconclusive.
Objective: This study was conducted to examine the association of GI and GL with clinical cardiovascular
disease (CVD) risk factors including body weight, blood pressure (BP), serum lipids, fasting glucose, insulin
and homocysteine over time among the PREMIER participants.
Design: PREMIER was an 18-month randomized lifestyle intervention trial, conducted from 2000 to 2002,
designed to help participants reduce BP by following the Dietary Approaches to Stop Hypertension (DASH)
dietary pattern, losing weight, reducing sodium and increasing physical activity. GI and GL were estimated
from 24 h diet recall data at baseline, 6 and 18 months after intervention. PROC MIXED model was used to
examine the association of changes in GI or GL with changes in CVD risk factors.
Results: A total of 756 randomized participants, 62% females and 34% African Americans and who averaged
50.090.3 years old and 95.390.7 kg, were included in this report. Neither GI nor GL changes was associated
with changes in any risk factors at 6 months. At 18 months, however, the GI change was significantly and
positively associated with total cholesterol (TC) change only (pB0.05, b23.80912.11 mg/dL or 0.6290.31
mmol/L) with a significant age interaction. The GL change was significantly associated with TC (p0.02,
b0.2890.15 mg/dL or 0.0190.00 mmol/L) positively and with low density lipoprotein cholesterol (LDL-C)
changes negatively (p0.03, b0.0190.00 mg/dL or 0.0090.00 mmol/L), and significant age
interactions were observed for both.
Conclusion: GI and GL was associated with TC and LDL-C after controlling for energy, fat and fiber intake
and other potential confounders and the associations were modified by age. Further investigation into this
relationship is important because of its potential clinical impact.
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S
ince 1981 the glycemic index (GI) has been used to
rank foods based on their effect on postprandial
glycemia (1). The concept of glycemic load (GL),
which incorporates the amount of carbohydrates con-
sumed into the equation, was later developed to further
quantify the glycemic effect of foods. Numerous studies
have examined the potential physiological impact of GI
and GL but their clinical significance remains deba-
table. Some cross-sectional or prospective observational
studies show an association between GI and GL with
cardiovascular disease (CVD) risk factors (24), but not
all (5, 6). Randomized controlled trials have also shown
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studies have shown that a reduced GI or GL is associated
with a reduced risk for CVD, coronary heart disease and
diabetes mellitus (2, 3, 10, 11). However, other studies
have not reported such an association (5, 12, 13). Overall,
results from studies examining the association between
GI and/or GL and CVD risk factors including blood
pressure (BP), insulin and lipids have not been consistent.
Further, to date, relatively little information has been
published on the long-term effects of changes in dietary
GI or GL with changes in CVD risk markers. The
PREMIER study offered an opportunity to examine
these associations more fully because of its longer term
design and the substantial number of participants re-
cruited. The primary objective of this paper is to examine
the association of GI and GL with clinical CVD risk
factors including body weight, BP, serum lipids, fasting
glucose, insulin and homocysteine over 18 months period
of time among the PREMIER participants. Even though
the causal relationship between homocysteine and CVD
has not been established yet, many studies have shown an
association between this marker and CVD risk (14).
In addition, research has also suggested that glycemic
control, such as in the expression of insulin secretion,
may affect homocysteine level (15). Thus, this marker is
also included in the current analysis.
Methods
Study design
PREMIER was a randomized clinical trial, conducted
from 2000 to 2002, designed to determine the effects
of two multi-component lifestyle interventions on BP.
Detailed descriptions of the study design, the interven-
tion programs and the main results have been published
elsewhere (16, 17). Participating institutions included the
National Heart Lung and Blood Institute (NHLBI)
Project Office [Bethesda, MD], the Coordinating Center
[Kaiser Permanente Center for Health Research in
Portland, OR] and four clinical centers [Duke
University Medical Center, Durham, NC; Johns Hopkins
University, Baltimore, MD; Pennington Biomedical Re-
search Center, Baton Rouge, LA; and Kaiser Permanente
Center for Health Research, Portland, OR]. Institutional
review boards at each center and an external protocol
review committee approved the protocol. Each partici-
pant provided written informed consent.
Study participants
A total of 810 participants were recruited and rando-
mized into the study. Individuals were eligible if they were
age 25 or older, had a BMI of 1845 kg/m
2, were not
taking anti-hypertensive medication and had a systolic
BP (SBP) of 120159 mmHg and diastolic BP (DBP) of
8095 mmHg, based on the mean BP over three screening
visits. Major exclusion criteria were regular use of drugs
that affect BP, including the Sixth Report of the Joint
National Committee on Prevention, Detection, Evalua-
tion, and Treatment of High Blood Pressure (JNC-VI)
risk category C [target organ damage and/or diabetes],
use of weight-loss medications, prior cardiovascular
event, heart failure, angina, cancer diagnosis or treatment
in the past 2 years, consumption of  21 alcoholic drinks/
week, and pregnancy, planned pregnancy, or lactation.
Intervention
After eligibility was established, study participants were
randomly assigned to one of three intervention groups:
(1) a behavioral lifestyle intervention that implemented
established recommendations [EST], (2) a behavioral
lifestyle intervention that implemented established re-
commendations plus the DASH dietary pattern [EST-
DASH], or (3) an advice only control group. The
intervention lasted a total of 18 months, with 6 months
of intensive intervention and 12 months of maintenance.
Both EST and EST-DASH participants received weekly
group sessions for the first 8 weeks, then bi-weekly
through the remainder of the first 6 months and monthly
for the last 12 months. Seven individual sessions were
interspersed throughout the 18 months. Trained and
certified interventionists, generally registered dietitians,
conducted all the intervention sessions.
Participants’ lifestyle goals for both the EST and EST-
DASH interventions were weight loss of at least 6.8 kg
(15 lb) at 6 months for those with a BMI]25 kg/m
2,
at least 180 min/week of moderate-intensity physical
activity, no more than 100 mmol/day of dietary sodium,
and no more than 30 ml (1 oz)/day of alcohol [two drinks]
for men and 15 ml (½ oz)/day [one drink] for women.
In addition, individuals in the EST-DASH intervention
were counseled to implement the DASH dietary pattern,
with the following goals: 912 servings of fruits and
vegetables, 23 servings of low-fat dairy products per day,
and intake of total and saturated fat of no more than
25 and 7% of total calories, respectively.
In contrast, the advice only control group received a
single 30 min individual advice session at the time of
randomization. At that session, participants received
verbal instruction, and written materials that provided
information on established recommendations and the
DASH dietary pattern. However, no behavioral counsel-
ing or further intervention contact was provided until
after completion of the 6-month data collection.
Measurements
All measurements were obtained at baseline, 6 and
18 months after randomization by staff who were blinded
to randomization assignment. Intake of nutrients
and food groups were assessed from unannounced
24-h dietary recalls conducted by telephone interviews.
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of the Pennsylvania State University at each study time
point [one week day and one weekend day] using the
Nutrition Data System for Research (NDS-R) (Nutrition
Coordinating Center, University of Minnesota, MN).
Across the four clinical sites, the completion rate of the
diet recall averaged over 90%. Average of the two recalls
for each time point was used for the analysis in this
report. For this report, dietary intake files were re-
calculated using Nutrition Data System for Research
(NDS-R) (Nutrition Coordinating Center, University of
Minnesota, Minneapolis, MN, version 2006) which con-
tains values for GI and GL in addition to updates to the
nutrient and food group files since the 1998 release of
NDS-R. GI values for daily totals, recipes and formula-
tions in the NDSR are calculated from the GI and
weighted by available carbohydrate of each ingredient
food. For foods where measured GI datawere unavailable
in the literature, GI was either estimated from similar
foods, calculated from available carbohydrate amounts
and the GI of ingredients within the food, or given a
default GI. Methodology for selection of GI values and
their incorporation into the database has been reported
elsewhere (18). NDS-R has a time-related feature that
enables the recalculation of data from previous versions
of the original data collected. GI and GL values were
adjusted for energy intake using the residual method (19).
Fasting blood was collected for the measurement of a
lipid profile, insulin, glucose and homocysteine (only
available for the baseline and 6-month visits) at a central
lab (Washington University, St. Louis) (20) following
standardized protocols. Lipid profile was assessed by
Hitachi 917 and glucose by Roche hexokinase method on
Hitachi 917, and insulin by Roche Elecsys 2010 (Roche
Diagnostics, Indianapolis, IN). The coefficient of varia-
tion for these assays ranged from 2.1 to 4.8%.
Statistical analysis
Only participants who had at least one diet recall at each
study visit were included in the analyses for this report
(N756). Initial analyses found that all treatment groups
changed GI and GL similarly; thus groups were com-
bined to examine overall associations of change and
change in CVD risk factors. PROC MIXED model (SAS
program v9.1, SAS Inc. Cary, NC) was used to examine
the association of changes in GI or GL with changes in
body weight and CVD risk factors including BP, lipids,
fasting insulin, glucose and homocysteine. Adjusted
effect estimates (beta coefficient) for each risk factor
and the associated p values are presented. Baseline
characteristics including age, gender, race, education,
cohort, site, and weight, energy intake, carbohydrate,
fat, fiber intakes were included in the analyses as
covariates. In addition, for risk factors for which we
observed a significant association with GI or GL at either
6 or 18 months, we additionally fit a model that included
interaction terms with age, gender and race. A p value
of B0.05 was considered statistically significant.
Results
Of the 756 randomized participants that were included in
this report, 62% were female, 34% were African Amer-
ican, 64% were non-Hispanic white and 2% were other
races. At baseline, these participants averaged 50.090.3
(mean9SD) years old and their average weight was
95.390.7 kg (21091.5 lb). Table 1 contains the mean
baseline intakes of energy, percent kcal from carbohy-
drate, protein, fats, blood lipid values and the changes
of these variables by quartiles of GI change at 6 and
18 months. After 6 months of intervention, all groups
reduced GI and GL values although the GI reduction was
quite small. The reduction remained until 18 months. In
addition, both GI and GL changes were significantly and
positively associated with changes in dietary intakes of
total fat, monounsaturated fat, saturated fat, energy and
fiber but inversely with changes in protein intake at both 6
and 18 months (all pB0.05, supplemental table). Both GI
and GL changes were significantly associated with
changes in polyunsaturated fat intake at 6 months but
only the association with GL remained significant at 18
months. Change in carbohydrate intake was significantly
and inversely associated with GI and GL changes at both
time points but with GI change at 18 months only.
Overall, GI and GL changes were not found to be asso-
ciated with body weight, BP, high density lipoportein-
cholesterol (HDL-C), triglycerides, or insulin, at either
6 or 18 months (Table 2). At 6 months, a significant race
interaction for GI change with low density lipoprotein-
cholesterol (LDL-C) (p0.04, b8.5194.21 mg/dL or
0.2290.11 mmol/L) was observed, however, no signifi-
cant association was found when further analyses were
conducted within separate racial groups. At 18 months,
the change in GI was significantly and positively asso-
ciated with a change in total cholesterol (TC) (pB0.05,
b23.8912.1 mg/dL or 0.6290.31 mmol/L) and there
was a significant age interaction (p0.01, b0.609
0.23 mg/dL or 0.0290.01 mmol/L). The greater the
reduction in GI was, the greater the decrease in TC. In
addition, the older the participants were, the lesser the
impact of GI changes on TC changes.
At 18 months, the change in GL was significantly
and positively associated with a change in TC (p0.02,
b0.2890.15 mg/dL or 0.0190.00 mmol/L) but inver-
sely with LDL-C ((p0.03, b0.0190.00 mg/dL
or 0.0090.00 mmol/L), and these associations were
significantly dependent on age (Table 2). The greater the
decrease in GL, the greater the reduction in TC but the
lesser the reduction in LDL-C. Furthermore, the older
the participants were, the lesser the impact of GL on
LDL-C changes. At 6 months, the GI change was weakly
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a
Mean9SD 6-month quartile 18-month quartile
(N) Baseline 1 (172) 2 (172) 3 (173) 4 (172) 1 (182) 2 (182) 3 (183) 4 (182)
GI D 6091 4.0890.43 3.4390.11 3.0790.10 2.6490.20 3.6590.47 2.9690.12 2.5990.10 2.1490.22
Energy D, Mjoule 8.1692.61 2.8392.78 1.5091.89 0.4591.86 0.6291.85 3.1492.52 1.2391.92 0.391.87 0.7291.70
Carbohydrate D,E %
b 51.199.6 4.52910.87 5.14910.92 4.04910.88 2.44913.21 3.31910.37 3.56910.43 1.89910.59 2.27913.31
Protein D, E% 15.994.0 1.8994.52 1.2094.08 1.6595.05 0.8896.26 2.094.46 1.8494.75 1.4695.13 1.1295.82
Total Fat D, E% 33.297.6 5.8798.85 5.5399.64 4.6999.42 3.16910.77 4.8399.05 4.5598.61 2.8099.17 2.86910.81
SFA D, E% 11.093.2 1.9893.94 2.1194.20 1.6693.75 1.1694.43 1.6293.65 2.0593.58 1.0493.81 1.4793.99
PFA D, E% 6.892.5 1.1293.05 1.0392.78 0.8892.91 0.3993.30 0.6693.49 0.6693.15 0.8392.85 0.0193.49
MFA D, E% 12.793.4 2.5494.12 2.1394.27 1.9494.18 1.4394.79 2.2694.35 1.6993.99 0.8894.43 1.2094.87
Dietary cholesterol D, mg 2769161 118.99252.2 61.429181.3 30.459167.4 3.879149.3 119.69224.6 50.829178.6 9.419166.4 6.699145.3
Total Chol D, mmol/L 5.4891.0 0.3190.66 0.2990.68 0.3090.58 0.2290.66 0.4490.92 0.3290.83 0.3090.75 0.4090.87
LDL chol D, mmol/L 3.5090.89 0.1890.56 0.2490.57 0.2490.52 0.2090.60 0.4090.87 0.3290.82 0.3190.73 0.3690.81
HDL chol D, mmol/L 1.2690.34 0.0190.15 0.0290.17 0.0390.16 0.0390.16 0.0390.15 0.0190.19 0.0190.18 0.0190.18
Triglyceride D, mmol/L 1.6291.13 0.2690.77 0.0990.96 0.0590.79 0.0390.75 0.2590.76 0.1790.76 0.1290.68 0.1090.53
GL D 141942 85.44939.15 28.86910.21 2.72910.09 40.91917.94 88.02940.52 28.8899.85 3.4099.06 41.30919.34
aAll values expressed are mean9SD of changes by quartiles of GI change values.
bE%Energy percent.
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4Table 2. Association of changes in body weight and cardiovascular risk factors with changes in GI and GL at 6 or 18 months
a
6-month change in GI 18-month change in GI 6-month change in GL 18-month change in GL
Risk factor b9SE p value b9SE p value b9SE p value b9SE p value
Body weight, kg 4.2894.75 0.37 5.8895.77 0.31 0.0590.06 0.39 0.0590.07 0.53
SBP, mmHg 1.0894.31 0.80 2.9594.80 0.54 0.0590.06 0.38 0.0290.06 0.78
DBP, mmHg 1.8293.01 0.55 0.6293.27 0.85 0.0490.04 0.28 0.0090.04 0.99
TC, mmol/L
b 0.2790.32 0.41 0.6290.31 0.05
c 0.0090.00 0.92 0.0190.00 0.02
d
LDL-C, mmol/L 0.0890.30 0.79
e 0.2890.29 0.10 0.0090.00 0.74 0.0090.00 0.03
d
HDL-C, mmol/L 0.0590.08 0.54 0.1590.09 0.09 0.0090.00 0.42 0.0090.00 0.18
Triglyceride mmol/L 0.3590.41 0.40 0.5990.36 0.10 0.0190.01 0.20 0.0090.00 0.96
Fasting insulin, pmol/L 17.4926.4 0.51 45.5935.5 0.20 0.2490.33 0.48 0.2790.44 0.54
Fasting glucose, mmol/L 0.6890.37 0.06 0.2590.40 0.53 0.0090.01 0.37 0.0090.01 0.58
Homocysteine, mmol/L 7.8994.33 0.07 NA NA 0.0190.06 0.88 NA NA
aAll models were adjusted for energy intake, percent kcal from carbohydrate, percent kcal from fat, fiber, age, gender, race, education, treatment and cohort. b: adjusted effect estimates, TC: total cholesterol,
LDL-C: Low density lipoprotein cholesterol, HDL-C: high density lipoprotein cholesterol.
bMultiplication factors used to convert the conventional unit to the SI units: TC 0.0259; LDL-C 0.0259; HDL-C 0.0259; triglyceride 0.0113; insulin 6.945; glucose 0.0555; and homocysteine 7.397.
cThe p value was B0.05 but rounded to 0.05 for consistent presentation. The interaction term GIage was statistically significant at 18 months for TC (p0.01, b0.0290.01 mmol/L).
dThe interaction term GLage was statistically significant at 18 months for TC (p0.03, b0.0090.00 mmol/L) and LDL-C (p0.03, b0.090.0 mmol/L).
eThe interaction term GIRace was statistically significant at 6 months for LDL-C (p0.04, b0.2290.11 mmol/L), however, when the same model was analyzed for the two racial groups separately, neither
showed a significant association.
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)associated with changes in fasting glucose and homo-
cysteine level in an inverse direction (p0.06 and 0.07,
respectively).
Discussion
Overall, the finding from this study suggests that GI and
GL changes are associated with TC and LDL changes. In
addition, the older the participants, the lesser the impact
of GL changes on TC and LDL-C. In other words, the
older the participant, a greater increase in GL was
associated with a smaller increase in TC and a smaller
decrease in LDL-C. This is consistent with a previous
study which showed that younger participants were
expected to reduce LDL-C more than older participants
did in response to weight loss (21). It is, however, unclear
why the association of GL with TC and LDL-C was in
opposite direction.
Although several previous studies have found an
association between GI and/or GL with some CVD risk
factors (24), not all studies observed an association
(56). Similarly, a recent meta-analysis of observational
studies reported that a low GI or GL diet is associated
with a reduced risk of diabetes and heart disease (10), but
other reports did not find an association (12, 22, 23). In a
small cross-sectional study (2) of 32 Japanese women,
dietary GI and GL were positively associated with
triacylglycerol and negatively with HDL-C. Likewise,
using data from 13,907 participants in the NHANES
III survey and 7,321 Caucasian Whitehall II participants
(4, 6), a higher GI and GL were found to be associated
with a lower HDL-C. In another study of 1,354 Japanese
farmers, Murakami reported the following: a positive
association between GI and BMI, triacylglycerol, and
fasting glucose; a significant and positive association
between GL and triacyglyerol and fasting glucose; and a
negative association between GL and HDL-C (24).
However, in three other studies (23, 25), no clear links
were detected between GI or GL with body weight or
other CVD risk factors.
When the impact of GI and/or GL on CVD risk
factors was examined in randomized controlled trials,
results have similarly been inconsistent. A low GI and/or
GL diet was found to increase weight loss in the short
term (26), and to decrease both LDL-C (27) and
triacylglyerol (28), while other investigators reported
that low GI and/or GL diets had no impact on weight
loss or CVD risk factors (5, 8) (28, 29). A review of
14 earlier intervention studies, however, reported that a
low GI diet often resulted in lower triglycerides, LDL-C
and TC to HDL-C ratios (30). It is possible that if GI or
GL is associated with any of the CVD risk factors, it
exists in certain subgroups only (i.e. men, certain age
groups) (31). One study (32) found that the association
between GL and triacylglycerol was nearly four times
greater among women with BMI]25 than among those
with BMIB25. Another reported that GI was directly
related to TC changes in men and to LDL-C in women
and both relationships were modified by age, stronger for
younger than for older participants (31). A recent study
also showed that increasing high-GI foods and increasing
GL were significantly associated with an increase in all
risk for CHD in women only but not men (33). Indeed,
older individuals may have a slower initial glycemic
response as compared to younger individuals (34).
These observations are consistent with the current
findings of a significant age interaction for the associa-
tion between GI and TC and between GL and TC and
LDL-C.
The finding of an inverse association between GI
change and homocysteine level is consistent with pre-
vious findings that plasma homocysteine was directly
associated with insulin resistance and a low GI diet
tended to decrease homocysteine level (35). It was
hypothesized that a high GI diet may increase homo-
cysteine by inhibiting hepatic expression of cystathionine
b-synthase which catalyzes the transsulfuration from
homocysteine to cystathionine (15).
A potential explanation for the association of GI to
CVD risk factors may relate to its potential contribution
to insulin resistance (3). Consumption of high GI or
GL diets long term accumulatively may contribute to
aggravated postprandial glycemia and subsequently
insulin resistance and disordered lipid profile. Although
this study did not find a significant association between
GI or GL and fasting glucose or insulin levels, it is
possible that the high glycemic effect of a high GI or GL
diet may affect serum lipids through, at least in part, its
impact on insulin and its lipogenic effect (30).
Since energy intake was controlled for in all analytical
models and both GI and GL changes traveled closely
with changes in energy intake, it is possible that any
potential association between GI and/or GL and the risk
factors may have been masked by the impact of energy
intake on the risk factors. The possibility of under-
reporting in dietary intake may also have impacted the
classification of GI and/or GL and thus the association
with the risk factors.
This study cannot exclude the possibility that an
association between GI and/or GL and CVD risk factors
may truly be non-existent. The current study design,
sample size and/or data collection structure may also
have limited the detection of the association. Indeed, a
recent report shows that the short term glycemic response
(2 h as in the case of GI or GL) may not represent the
long term glycemic impact (36). In addition, different
types of carbohydrate (such as fructose and glucose) may
have different metabolic effects. Some have suggested that
a fructose index may be more relevant for CVD risk than
GI (37). Since the PREMIER study was not designed to
examine this question initially, there is the possibility of
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Thus, the results of this study should be viewed as
exploratory for hypotheses-generating and interpreted
with caution and be verified with future independent
studies. Other limitations of the study include inherent
issues with all dietary data collections and the fact that
two 24-h dietary recalls may not capture usual intake of
the population. However, the assessment methodologies
of dietary intake and GI and GL values used in this study
are commonly adopted by other studies and are similar to
the studies reviewed above.
Further, it is unclear how the ranges of GI and GL
examined in previous studies affected associations with
CVD risk factors. When comparing to previous studies,
the mean GI and GL values ( 60/140) observed in the
current study can be considered either low (32) or high
(3). How such discrepancy in defining a high or low GI or
GL value may explain the observed inconsistent findings
is not clear. Nevertheless, it is possible that if a relation-
ship between GI or GL and CVD factors exists, it exists
in a continuous fashion across a wide range of GI
and GL values and this is how it was examined in this
report.
Although the PREMIER intervention was not speci-
fically designed to change dietary GI or GL, it is obvious
that the intervention helped to reduce both. Reduction
in GL could have been achieved by replacing intake of
high-GI foods with low-GI foods and/or lowering of
carbohydrate foods overall. These strategies may impact
metabolism differently and so may have contributed to
the variable results observed. The fact that participants
may have reduced carbohydrate foods overall may also
explain the finding that both GI and GL changes were
significantly and positively associated with changes in
energy intake.
Even though GI and GL concept is not officially
promoted by the American Diabetes Association, this
concept is supported and practiced by some diabetolo-
gists and is widely promoted by many entities in the
public domain. Thus, it is important to clarify the clinical
impact of GI and/or GL. In addition, since the diabetic
population is especially at risk for cardiovascular events,
it is important to understand more about the association
between GI and GL and lipids and other CVD risk
factors. As the result of this study indicates, a healthy
eating intervention improves GI and GL and thus GI and
GL can provide a mean to evaluate dietary quality in
epidemiological studies. However, attention should be
given to methodological issues related to usage of
different dietary assessments and reliability of GI and
GL estimates (38).
Conclusion
The current results suggest relatively weak associations
between dietary GI and GL with changes in TC and
LDL-C that are evident after 18 months, but not after
6 months of the intervention. The measurement of GI
and GL still holds its promise in predicting CVD risk and
in refining CVD risk reduction program based on the
current and other studies, further investigation into this
relationship is important because of its potential clinical
impact. Inclusion of GI and GL concept in dietary
intervention or public health nutrition education pro-
gram may enhance the quality and complement the entire
intervention. In addition, clinical implementation of
GI and GL may benefit from incorporating additional
dietary considerations so that the resulting dietary
changes may achieve the maximum potential for CVD
health.
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